e-learning
resources
Vienna 2003
Sunday 28.09.2003
Pulmonary disease in systemic disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung ventilation function before and after therapy of arterial hypertension by different antihypertensive drugs
L. Corkovic, N. Kostic, T. Milosevic, S. Ignjatovic (Belgrade, Kragujevac, Yugoslavia)
Source:
Annual Congress 2003 - Pulmonary disease in systemic disorders
Session:
Pulmonary disease in systemic disorders
Session type:
Thematic Poster Session
Number:
423
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Corkovic, N. Kostic, T. Milosevic, S. Ignjatovic (Belgrade, Kragujevac, Yugoslavia). Lung ventilation function before and after therapy of arterial hypertension by different antihypertensive drugs. Eur Respir J 2003; 22: Suppl. 45, 423
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Haemodynamic effects of exercise therapy in stable, optimally treated pulmonary arterial hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Adherence to pulmonary arterial hypertension targeted therapies
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Combination therapy with sildenafil and sitaxentan therapy for pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy
Source: ERJ Open Res, 7 (1) 00725-2020; 10.1183/23120541.00725-2020
Year: 2021
Therapeutic limitations of oral medications to normalize hemodynamics in patients with pulmonary artery hypertension.
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
Patterns of therapy with sildenafil among patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Initial dual oral combination therapy for pulmonary arterial hypertension (PAH) in daily practice
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Long-term improvement of pulmonary haemodynamics and exercise capacity in patients with pulmonary hypertension and hypoventilation following NIPPV and influence of NIPPV adherence
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Initial dual oral combination therapy in pulmonary arterial hypertension
Source: Eur Respir J 2016; 47:1727-1736
Year: 2016
Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Pharmacokinetic interactions of imatinib with bosentan and sildenafil for treatment of severe pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
General and standard therapy of pulmonary arterial hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Impact of therapies on insulin resistance in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Initial combination therapy with epoprostenol and bosentan in severe pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
The effect of anti-oxidant therapy on pulmonary functions and arterial blood gases in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 405-413
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept